OR4F29 | Olfactory receptor, family 4, subfamily F, member 29 | G-protein coupled receptors Predicted membrane proteins
| | | | | Not detected |
OR4F16 | Olfactory receptor, family 4, subfamily F, member 16 | G-protein coupled receptors Predicted membrane proteins
| | | | | Not detected |
SAMD11 | Sterile alpha motif domain containing 11 | | | | | | Mixed |
NOC2L | Nucleolar complex associated 2 homolog (S. cerevisiae) | | | | | | Expressed in all |
KLHL17 | Kelch-like family member 17 | | | | | | Mixed |
PLEKHN1 | Pleckstrin homology domain containing, family N member 1 | | | | | | Group enriched |
C1orf170 | Chromosome 1 open reading frame 170 | | | | | | Tissue enhanced |
ISG15 | ISG15 ubiquitin-like modifier | | | | | | Expressed in all |
AGRN | Agrin | Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
C1orf159 | Chromosome 1 open reading frame 159 | Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
TTLL10 | Tubulin tyrosine ligase-like family, member 10 | | | | | | Group enriched |
TNFRSF18 | Tumor necrosis factor receptor superfamily, member 18 | CD markers Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
TNFRSF4 | Tumor necrosis factor receptor superfamily, member 4 | Cancer-related genes CD markers Disease related genes Predicted membrane proteins
| | | | | Mixed |
SDF4 | Stromal cell derived factor 4 | Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
FAM132A | Family with sequence similarity 132, member A | Predicted secreted proteins
| | | | | Tissue enhanced |
UBE2J2 | Ubiquitin-conjugating enzyme E2, J2 | Enzymes Predicted membrane proteins
| | | | | Expressed in all |
SCNN1D | Sodium channel, non-voltage-gated 1, delta subunit | FDA approved drug targets Predicted membrane proteins
| | | | | Mixed |
ACAP3 | ArfGAP with coiled-coil, ankyrin repeat and PH domains 3 | | | | | | Expressed in all |
PUSL1 | Pseudouridylate synthase-like 1 | | | | | | Expressed in all |
CPSF3L | Cleavage and polyadenylation specific factor 3-like | Plasma proteins
| | | | | Expressed in all |
GLTPD1 | Glycolipid transfer protein domain containing 1 | | | | | | Expressed in all |
TAS1R3 | Taste receptor, type 1, member 3 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
DVL1 | Dishevelled segment polarity protein 1 | Plasma proteins
| | | | | Expressed in all |
MXRA8 | Matrix-remodelling associated 8 | Predicted membrane proteins
| | | | | Expressed in all |
AURKAIP1 | Aurora kinase A interacting protein 1 | | | | | | Expressed in all |
CCNL2 | Cyclin L2 | Predicted secreted proteins
| | | | | Expressed in all |
RP4-758J18.2 | HCG20425, isoform CRA_a; Uncharacterized protein; cDNA FLJ53815 | | | | | | Expressed in all |
MRPL20 | Mitochondrial ribosomal protein L20 | Mitochondrial proteins Ribosomal proteins
| | | | | Expressed in all |
ANKRD65 | Ankyrin repeat domain 65 | | | | | | Tissue enhanced |
TMEM88B | Transmembrane protein 88B | Predicted membrane proteins
| | | | | Tissue enriched |
VWA1 | Von Willebrand factor A domain containing 1 | Predicted secreted proteins
| | | | | Tissue enhanced |
ATAD3B | ATPase family, AAA domain containing 3B | | | | | | Expressed in all |
ATAD3A | ATPase family, AAA domain containing 3A | | | | | | Expressed in all |
AL645728.1 | Uncharacterized protein | | | | | | Tissue enhanced |
MIB2 | Mindbomb E3 ubiquitin protein ligase 2 | | | | | | Expressed in all |
MMP23B | Matrix metallopeptidase 23B | Enzymes FDA approved drug targets
| | | | | Mixed |
SLC35E2B | Solute carrier family 35, member E2B | Predicted membrane proteins Transporters
| | | | | Expressed in all |
CDK11A | Cyclin-dependent kinase 11A | Enzymes
| | | | | Expressed in all |
SLC35E2 | Solute carrier family 35, member E2 | Predicted membrane proteins
| | | | | Expressed in all |
NADK | NAD kinase | Enzymes
| | | | | Expressed in all |
GNB1 | Guanine nucleotide binding protein (G protein), beta polypeptide 1 | Cancer-related genes Plasma proteins RAS pathway related proteins
| | | | | Expressed in all |
CALML6 | Calmodulin-like 6 | RAS pathway related proteins
| | | | | Tissue enriched |
TMEM52 | Transmembrane protein 52 | Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
C1orf222 | Chromosome 1 open reading frame 222 | | | | | | Tissue enhanced |
GABRD | Gamma-aminobutyric acid (GABA) A receptor, delta | Disease related genes FDA approved drug targets Predicted membrane proteins
| | | | | Tissue enriched |
PRKCZ | Protein kinase C, zeta | Enzymes Plasma proteins
| | | | | Mixed |
C1orf86 | Chromosome 1 open reading frame 86 | | | | | | Expressed in all |
AL590822.1 | Uncharacterized protein | | | | | | Not detected |
SKI | V-ski avian sarcoma viral oncogene homolog | Plasma proteins
| | | | | Expressed in all |
MORN1 | MORN repeat containing 1 | | | | | | Expressed in all |